Open Access. Powered by Scholars. Published by Universities.®
Congenital, Hereditary, and Neonatal Diseases and Abnormalities Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Female (2)
- Humans (2)
- Infant (2)
- Male (2)
- Administration, Inhalation (1)
-
- Adolescent (1)
- Anti-Bacterial Agents (1)
- Azithromycin (1)
- Bacteremia (1)
- Bibliometrics (1)
- CF (1)
- Child (1)
- Child, Preschool (1)
- Children (1)
- Children's Hospitals Neonatal Consortium (CHNC) (1)
- Children's Hospitals Neonatal Database (CHND) (1)
- Clinical trial (1)
- Congenital diaphragmatic hernia (1)
- Cystic Fibrosis (1)
- Double-Blind Method (1)
- Drug Therapy, Combination (1)
- Emergency Service, Hospital (1)
- Eradication (1)
- Fever (1)
- Follow-Up Studies (1)
- Incidence (1)
- Infant, Newborn (1)
- Journal Productivity (1)
- Neonatal intensive care (1)
- Ototoxicity (1)
- Publication
- Publication Type
Articles 1 - 4 of 4
Full-Text Articles in Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Risk Stratification Of Febrile Infants ≤60 Days Old Without Routine Lumbar Puncture., Paul L. Aronson, Marie E. Wang, Eugene D. Shapiro, Samir S. Shah, Adrienne G. Deporre, Russell J Mcculloh, Christopher M. Pruitt, Sanyukta Desai, Lise E. Nigrovic, Richard D. Marble, Rianna C. Leazer, Sahar N. Rooholamini, Laura F. Sartori, Fran Balamuth, Christopher Woll, Mark I. Neuman, Febrile Young Infant Research Collaborative
Risk Stratification Of Febrile Infants ≤60 Days Old Without Routine Lumbar Puncture., Paul L. Aronson, Marie E. Wang, Eugene D. Shapiro, Samir S. Shah, Adrienne G. Deporre, Russell J Mcculloh, Christopher M. Pruitt, Sanyukta Desai, Lise E. Nigrovic, Richard D. Marble, Rianna C. Leazer, Sahar N. Rooholamini, Laura F. Sartori, Fran Balamuth, Christopher Woll, Mark I. Neuman, Febrile Young Infant Research Collaborative
Manuscripts, Articles, Book Chapters and Other Papers
Video Abstract: media-1vid110.1542/5840460609001PEDS-VA_2018-1879
OBJECTIVES: To evaluate the Rochester and modified Philadelphia criteria for the risk stratification of febrile infants with invasive bacterial infection (IBI) who do not appear ill without routine cerebrospinal fluid (CSF) testing.
METHODS: We performed a case-control study of febrile infants ≤60 days old presenting to 1 of 9 emergency departments from 2011 to 2016. For each infant with IBI (defined as a blood [bacteremia] and/or CSF [bacterial meningitis] culture with growth of a pathogen), controls without IBI were matched by site and date of visit. Infants were excluded if they appeared ill or had a …
Azithromycin For Early Pseudomonas Infection In Cystic Fibrosis. The Optimize Randomized Trial., Nicole Mayer-Hamblett, George Retsch-Bogart, Margaret Kloster, Frank Accurso, Margaret Rosenfeld, Gary Albers, Philip Black, Perry Brown, Annemarie Cairns, Stephanie D. Davis, Gavin R. Graff, Gwendolyn S. Kerby, David Orenstein, Rachael Buckingham, Bonnie W. Ramsey, Optimize Study Group
Azithromycin For Early Pseudomonas Infection In Cystic Fibrosis. The Optimize Randomized Trial., Nicole Mayer-Hamblett, George Retsch-Bogart, Margaret Kloster, Frank Accurso, Margaret Rosenfeld, Gary Albers, Philip Black, Perry Brown, Annemarie Cairns, Stephanie D. Davis, Gavin R. Graff, Gwendolyn S. Kerby, David Orenstein, Rachael Buckingham, Bonnie W. Ramsey, Optimize Study Group
Manuscripts, Articles, Book Chapters and Other Papers
RATIONALE: New isolation of Pseudomonas aeruginosa (Pa) is generally treated with inhaled antipseudomonal antibiotics such as tobramycin inhalation solution (TIS). A therapeutic approach that complements traditional antimicrobial therapy by reducing the risk of pulmonary exacerbation and inflammation may ultimately prolong the time to Pa recurrence.
OBJECTIVES: To test the hypothesis that the addition of azithromycin to TIS in children with cystic fibrosis and early Pa decreases the risk of pulmonary exacerbation and prolongs the time to Pa recurrence.
METHODS: The OPTIMIZE (Optimizing Treatment for Early Pseudomonas aeruginosa Infection in Cystic Fibrosis) trial was a multicenter, double-blind, randomized, placebo-controlled, 18-month trial …
Bibliometric Analysis Of Scholarly Publications On The Zika Virus, 1952-2016, Frances A. Delwiche
Bibliometric Analysis Of Scholarly Publications On The Zika Virus, 1952-2016, Frances A. Delwiche
University Libraries Faculty and Staff Publications
The 2015-2016 epidemic in the Americas caused by the Zika Virus (ZIKV) triggered a dramatic increase in the number of scholarly publications on this topic. In an effort to understand and characterize this body of literature, a bibliometric study was conducted on all articles found in PubMed that were published on the Zika virus between 1952 and 2016. Study parameters included publication date, source journal, subject and category of source journal, and country of first author. The data was frequency-ranked, enabling identification of the most highly productive journal titles, subject areas, and countries. The study concluded with a comparison between …
Sustainability And Outcomes Of A Standardized Aminoglycoside Induced Ototoxicity Monitoring Algorithm, Claire Elson, Christopher M. Oermann, Michelle Weltman, Ellen Meier
Sustainability And Outcomes Of A Standardized Aminoglycoside Induced Ototoxicity Monitoring Algorithm, Claire Elson, Christopher M. Oermann, Michelle Weltman, Ellen Meier
Posters
No abstract provided.